FindTrial
Sign In

Construction and validation of a risk stratification system for cervical lymph node metastasis based on MRI

Construction and validation of a risk stratification system for cervical lymph node metastasis based on MRI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120228
Enrollment
Unknown
Registered
2026-03-11
Start date
2026-03-15
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Differentiated thyroid carcinoma

Interventions

Gold Standard:Pathological results of cervical lymph nodes
Index test:Prediction model for cervical lymph node metastasis of thyroid cancer

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.prior total thyroidectomy; 2.pathologically confirmed DTC; 3.cervical MRI examination performed more than six months after total thyroidectomy;

Exclusion criteria

Exclusion criteria: 1.receipt of targeted therapy, radiotherapy, or chemotherapy; 2.presence of distant metastasis; 3.coexisting malignancies; 4.high-risk histological subtypes of DTC; 5.incomplete clinical or imaging data;

Design outcomes

Primary

MeasureTime frame
The status of cervical lymph node metastasis;—

Countries

China

Contacts

Public ContactMing Jie

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

mingjiewh@126.com+86 13995519049

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026